1. Home
  2. FOUR vs HAE Comparison

FOUR vs HAE Comparison

Compare FOUR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shift4 Payments Inc.

FOUR

Shift4 Payments Inc.

HOLD

Current Price

$66.74

Market Cap

4.7B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$82.23

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOUR
HAE
Founded
1999
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.9B
IPO Year
2020
1991

Fundamental Metrics

Financial Performance
Metric
FOUR
HAE
Price
$66.74
$82.23
Analyst Decision
Buy
Buy
Analyst Count
22
9
Target Price
$99.32
$88.38
AVG Volume (30 Days)
1.6M
665.0K
Earning Date
02-17-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
14.66
42.54
EPS
2.15
3.44
Revenue
$3,878,400,000.00
$1,327,850,000.00
Revenue This Year
$28.69
N/A
Revenue Next Year
$24.52
$6.01
P/E Ratio
$30.76
$24.46
Revenue Growth
23.16
N/A
52 Week Low
$61.23
$47.32
52 Week High
$127.50
$87.32

Technical Indicators

Market Signals
Indicator
FOUR
HAE
Relative Strength Index (RSI) 51.64 58.69
Support Level $61.42 $79.06
Resistance Level $66.25 $86.11
Average True Range (ATR) 2.14 1.68
MACD 0.44 -0.27
Stochastic Oscillator 91.51 43.33

Price Performance

Historical Comparison
FOUR
HAE

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: